70 likes | 73 Views
Antibody drug conjugates (ADC) market size is projected to grow at a compound annual growth rate of 23.7% over the forecast period of 2022 to 2029
E N D
Antibody Drug Conjugates (ADC) Market by Global Demand, Supply and Research Synopsis Antibody Drug Conjugates (ADC) Market, By Target (Antibody-Protein Toxin Conjugates, Antibody-Chelated Radionuclide Conjugates, Antibody-Small-Molecule Drug Conjugates, Antibody-Enzyme Conjugates), Product (Adcertis, Kadcyla, Others), Mechanism of Action (CD30 Antibodies, HER2 Antibodies), Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Others), Indication (Lymphoma, Breast Cancer, Brain Tumor, Lung Cancer, Ovarian Cancer, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Industry Trends and Forecast to 2029. Browse Full Report : https://www.databridgemarketresearch.com/reports/global-antibody-drug-conjugates-market
Market Analysis and Insights Antibody drug conjugates (ADC) market size is projected to grow at a compound annual growth rate of 23.7% over the forecast period of 2022 to 2029. Data Bridge Market Research report on antibody drug conjugates (ADC) market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market’s growth. Antibody drug conjugates are basically the biopharmaceuticals agents that are manufactured for targeted therapy of cancer treatment. They are covalently linked to the antibody or antibody fragment that directed towards the specific cell surface target expressed on the tumor cells. They are combined with monoclonal antibodies to target the cancer cells and act by specifically targeting to the tumor antigen surface, the complex internalized into the cells. Get Exclusive Sample Report : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antibody-drug-conjugates-market
Major Key Players • Some of the major players operating in this market are : • SeagenInc. • Genentech Inc. • Pfizer Inc. • Novartis AG • F. Hoffmann-LA Roche Ltd. • Bristol -Myers Squibb • Merck & Co., Inc • ImmunomedicsInc., • Takeda Pharmaceutical Company Limited • OnconovaTherapeutics Inquire Before Buying : https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-antibody-drug-conjugates-market
Market Segmentation • ByTarget (Antibody-Protein Toxin Conjugates, Antibody-Chelated Radionuclide Conjugates, Antibody-Small-Molecule Drug Conjugates, Antibody-Enzyme Conjugates) • ByProduct (Adcertis, Kadcyla, Others) • ByTechnology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Others) Browse Full TOC : @ https://www.databridgemarketresearch.com/toc/?dbmr=global-antibody-drug-conjugates-market
Regional Analysis • Based on geography, the market is segmented into five geographical regions • North America • Europe • Asia-Pacific • South America • Middle East • Africa
About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com